Glenmark Asks Fed. Circ. To Nix Patent In $16M Abbott Win
Although Abbott's counsel John Allcock touted Tarka as an example of “inventor insight,” plucking the specific ACE inhibitor-calcium antagonist combination out of thousands of possibilities, Glenmark maintained those same alternatives show Tarka's patent protection was completely inappropriate.
“This is a...
To view the full article, register now.